"Invasive vs. Conservative Management in Cancer Patients With Non-ST Elevation MI (CAN-NSTEMI)"

CompletedOBSERVATIONAL
Enrollment

12,500

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

November 20, 2024

Study Completion Date

April 1, 2025

Conditions
Myocardial Infarction
Interventions
OTHER

Observational Study

This study does not involve any active intervention. It is an observational study comparing the outcomes of invasive and conservative treatment strategies for non-ST elevation myocardial infarction (NSTEMI) in cancer patients. The treatments are based on the clinical decisions made by the attending physicians

Trial Locations (1)

06200

Ankara Oncology Training and Research Hospital, Ankara

All Listed Sponsors
lead

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

OTHER

NCT06702436 - "Invasive vs. Conservative Management in Cancer Patients With Non-ST Elevation MI (CAN-NSTEMI)" | Biotech Hunter | Biotech Hunter